Clarivate PLC (CLVT): Price and Financial Metrics
CLVT Price/Volume Stats
| Current price | $9.30 | 52-week high | $11.99 |
| Prev. close | $9.22 | 52-week low | $6.07 |
| Day low | $9.18 | Volume | 2,221,600 |
| Day high | $9.41 | Avg. volume | 3,287,152 |
| 50-day MA | $8.78 | Dividend yield | N/A |
| 200-day MA | $8.01 | Market Cap | 6.17B |
CLVT Stock Price Chart Interactive Chart >
CLVT POWR Grades
- CLVT scores best on the Value dimension, with a Value rank ahead of 75.53% of US stocks.
- The strongest trend for CLVT is in Growth, which has been heading down over the past 26 weeks.
- CLVT ranks lowest in Sentiment; there it ranks in the 18th percentile.
CLVT Stock Summary
- CLVT's went public 5.33 years ago, making it older than just 21.55% of listed US stocks we're tracking.
- Over the past twelve months, CLVT has reported earnings growth of -109.66%, putting it ahead of merely 12.14% of US stocks in our set.
- CLARIVATE PLC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 12.4%, greater than the shareholder yield of 86.59% of stocks in our set.
- If you're looking for stocks that are quantitatively similar to CLARIVATE PLC, a group of peers worth examining would be EVTC, CXW, H, PHX, and MOS.
- CLVT's SEC filings can be seen here. And to visit CLARIVATE PLC's official web site, go to www.clarivate.com.
CLVT Valuation Summary
- CLVT's price/sales ratio is 2; this is 16.67% lower than that of the median Technology stock.
- Over the past 64 months, CLVT's price/sales ratio has gone up 1.2.
Below are key valuation metrics over time for CLVT.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| CLVT | 2023-12-08 | 2 | 0.8 | 29.5 | 25.3 |
| CLVT | 2023-12-07 | 2 | 0.8 | 29.5 | 25.3 |
| CLVT | 2023-12-06 | 2 | 0.8 | 29.1 | 25.1 |
| CLVT | 2023-12-05 | 2 | 0.8 | 28.9 | 25.0 |
| CLVT | 2023-12-04 | 2 | 0.8 | 29.5 | 25.3 |
| CLVT | 2023-12-01 | 2 | 0.8 | 29.5 | 25.3 |
CLVT's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- CLVT has a Quality Grade of F, ranking ahead of 3.32% of graded US stocks.
- CLVT's asset turnover comes in at 0.104 -- ranking 521st of 563 Business Services stocks.
- 500 - Internal server error
The table below shows CLVT's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-09-30 | 0.104 | 0.672 | -0.013 |
| 2021-06-30 | 0.118 | 0.671 | -0.050 |
| 2021-03-31 | 0.142 | 0.663 | -0.039 |
| 2020-12-31 | 0.164 | 0.682 | 0.001 |
| 2019-12-31 | 0.434 | 0.644 | -0.037 |
CLVT Price Target
For more insight on analysts targets of CLVT, see our CLVT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $34.00 | Average Broker Recommendation | 1.42 (Moderate Buy) |
Clarivate PLC (CLVT) Company Bio
Clarivate Plc engages in the provision of trusted insights and analytics to accelerate the pace of innovation. It operates through the Science and Intellectual Property segments. The Science segment comprises the academic and life science product lines. The Intellectual Property segment includes patent, trademark, domain, and IP management product lines. The company was founded in 1864 and is headquartered in London.
Latest CLVT News From Around the Web
Below are the latest news stories about CLARIVATE PLC that investors may wish to consider to help them evaluate CLVT as an investment opportunity.
Clarivate Reveals Stronger Outlook for Pulsed-field Ablation Market and Potential for Device to Revolutionize Treatment ParadigmClarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today announced the launch of a new special report series, Electrophysiology Mapping and Ablation Devices Market Insights. The Clarivate MedTech Insights reports reveal new forecast predictions for the ablation catheter market in four geographies: the US, Europe, Japan and Asia Pacific. Findings show pulsed-field ablation (PFA) is poised to revolutionize the |
Clarivate Expands Partnership with VeriSIM Life to Accelerate and De-risk Research and Drug DevelopmentClarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today announced the launch of VeriSIM Life Translational Index™ on Cortellis Drug Discovery Intelligence by Clarivate. The integrated workflow provides customers with a diverse array of predictive compound safety and efficacy insights, including bioavailability, hepatic and renal clearance, clinical toxicity, first-in-human dose and more. |
Clarivate Reveals World's Influential Researchers in Highly Cited Researchers 2023 ListClarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today revealed its 2023 list of Highly Cited Researchers™ – influential researchers at universities, research institutes and commercial organizations around the world who have demonstrated significant and broad influence in their field(s) of research. |
Clarivate to Present at the RBC Capital Markets 2023 Technology, Internet, Media and Telecommunications Conference on November 14, 2023Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a global leader in connecting people and organizations to intelligence they can trust to transform their world, announced today that Jonathan Gear, Chief Executive Officer, will present at the RBC Capital Markets 2023 Technology, Internet, Media and Telecommunications Conference on Tuesday, November 14, 2023 at 1:20 pm Eastern Time. |
Clarivate Reports Third Quarter 2023 ResultsClarivate Plc - (NYSE: CLVT) (the "Company" or "Clarivate"), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today reported results for the third quarter. |
CLVT Price Returns
| 1-mo | 3.10% |
| 3-mo | 41.55% |
| 6-mo | 30.80% |
| 1-year | -14.91% |
| 3-year | -68.74% |
| 5-year | N/A |
| YTD | 0.43% |
| 2023 | 11.03% |
| 2022 | -64.54% |
| 2021 | -20.83% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...